MissionIR Engaged by Cardium Therapeutics for Strategic Investor Relations Services
(firmenpresse) - ATLANTA, GA -- (Marketwire) -- 06/11/12 -- MissionIR, a full-service investor relations firm, today announces that they have been retained by Cardium Therapeutics, Inc. (NYSE MKT: CXM) to assist in implementing a strategic digital and social media investor relations campaign, an important part of Cardium's overall corporate communications strategy. Through a network of investor-oriented sites and a full suite of investor awareness services, MissionIR develops and executes investor awareness plans for companies in the small-cap markets.
"Cardium has clearly demonstrated their dedication to building on core products and product candidates to continually create new opportunities for greater success," stated Sherri Snyder, Director of Marketing at MissionIR. "Leveraging the advantages of its capital-efficient, asset-based business strategy, Cardium provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value."
Cardium is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering, and other economic monetizations. Cardium's current medical opportunities portfolio, which is focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Health Sciences healthy lifestyle product platform. For more information, visit .
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. Through a full suite of investor relations and consultancy services, we help public companies develop and execute a strategic investor awareness plan as we've done for hundreds of others. Whether it is capital raising, increasing awareness among the financial community, or enhancing corporate communications, we offer a variety of solutions to meet the objectives of our clients.
For more information, visit
Mission Investor Relations
Atlanta, Georgia
404-941-8975
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.06.2012 - 12:30 Uhr
Sprache: Deutsch
News-ID 154990
Anzahl Zeichen: 0
contact information:
Town:
ATLANTA, GA
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 180 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MissionIR Engaged by Cardium Therapeutics for Strategic Investor Relations Services"
steht unter der journalistisch-redaktionellen Verantwortung von
Mission Investor Relations (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
